Literature DB >> 10792459

Increased rewarding properties of morphine in dopamine-transporter knockout mice.

C Spielewoy1, F Gonon, C Roubert, V Fauchey, M Jaber, M G Caron, B P Roques, M Hamon, C Betancur, R Maldonado, B Giros.   

Abstract

The activation of dopamine (DA) neurotransmission plays a crucial role in the behavioural responses to drugs of abuse. In particular, increased extracellular levels of DA within the mesolimbic pathway have been implicated in the rewarding and locomotor stimulatory properties of morphine. We investigated the behavioural responses to morphine in mice with a genetic disruption of the DA transporter (DAT), resulting in a constitutively high level of extrasynaptic DA. In the conditioned place preference test, DAT-/- mice exhibited a stronger rewarding response to morphine (5 mg/kg, s.c.) compared with control littermates. However, the same dose of morphine failed to increase locomotor activity in DAT-/- mice, whilst enhancing locomotion in DAT+/- and DAT+/+ animals. Morphine-induced analgesia was unaffected in mutant mice, but the behavioural expression of naloxone-induced withdrawal signs was blunted. In vivo voltammetry in the shell of the nucleus accumbens revealed that morphine was able to stimulate DA neurons in DAT-/- mice, resulting in the accumulation of higher extracellular DA levels compared with control animals. Morphine also induced a higher rate of c-fos transcription in the shell of the nucleus accumbens in mutant mice. We conclude that morphine-induced rewarding responses are firmly established in DAT mutant mice despite a DA transmission that is already tonically activated, and independently of any effect on locomotion. These particular behavioural responses to morphine may be associated with the action of the drug on DA release and c-fos expression in the shell of the nucleus accumbens of DAT-/- mice.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10792459      PMCID: PMC1904481          DOI: 10.1046/j.1460-9568.2000.00063.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  51 in total

1.  Evidence for multiple opioid receptors in the human posterior pituitary.

Authors:  D Jordan; J A Tafani; C Ries; J M Zajac; G Simonnet; D Martin; N Kopp; M Allard
Journal:  J Neuroendocrinol       Date:  1996-11       Impact factor: 3.627

2.  Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene.

Authors:  H W Matthes; R Maldonado; F Simonin; O Valverde; S Slowe; I Kitchen; K Befort; A Dierich; M Le Meur; P Dollé; E Tzavara; J Hanoune; B P Roques; B L Kieffer
Journal:  Nature       Date:  1996-10-31       Impact factor: 49.962

3.  Absence of opiate rewarding effects in mice lacking dopamine D2 receptors.

Authors:  R Maldonado; A Saiardi; O Valverde; T A Samad; B P Roques; E Borrelli
Journal:  Nature       Date:  1997-08-07       Impact factor: 49.962

Review 4.  Molecular and cellular basis of addiction.

Authors:  E J Nestler; G K Aghajanian
Journal:  Science       Date:  1997-10-03       Impact factor: 47.728

5.  Drug abuse: hedonic homeostatic dysregulation.

Authors:  G F Koob; M Le Moal
Journal:  Science       Date:  1997-10-03       Impact factor: 47.728

6.  Dopamine-adenosine interactions in the striatum and the globus pallidus: inhibition of striatopallidal neurons through either D2 or A2A receptors enhances D1 receptor-mediated effects on c-fos expression.

Authors:  C Le Moine; P Svenningsson; B B Fredholm; B Bloch
Journal:  J Neurosci       Date:  1997-10-15       Impact factor: 6.167

7.  Involvement of opioid mu 1 receptors in morphine-induced conditioned place preference in rats.

Authors:  T P Piepponen; T Kivastik; J Katajamäki; A Zharkovsky; L Ahtee
Journal:  Pharmacol Biochem Behav       Date:  1997-09       Impact factor: 3.533

8.  Systemic morphine-induced Fos protein in the rat striatum and nucleus accumbens is regulated by mu opioid receptors in the substantia nigra and ventral tegmental area.

Authors:  B Bontempi; F R Sharp
Journal:  J Neurosci       Date:  1997-11-01       Impact factor: 6.167

Review 9.  Molecular mechanisms of drug addiction: adaptations in signal transduction pathways.

Authors:  E J Nestler; M T Berhow; E S Brodkin
Journal:  Mol Psychiatry       Date:  1996-07       Impact factor: 15.992

10.  Profound neuronal plasticity in response to inactivation of the dopamine transporter.

Authors:  S R Jones; R R Gainetdinov; M Jaber; B Giros; R M Wightman; M G Caron
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

View more
  20 in total

Review 1.  Cognitive effects of nicotine: genetic moderators.

Authors:  Aryeh I Herman; Mehmet Sofuoglu
Journal:  Addict Biol       Date:  2010-04-29       Impact factor: 4.280

2.  Enhanced tyrosine hydroxylase phosphorylation in the nucleus accumbens and nucleus tractus solitarius-A2 cell group after morphine-conditioned place preference.

Authors:  A González-Cuello; L Mora; J M Hidalgo; N Meca; C Lasheras; M V Milanés; M L Laorden
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-10-06       Impact factor: 3.000

Review 3.  GSK-3β activity and hyperdopamine-dependent behaviors.

Authors:  Yan-Chun Li; Wen-Jun Gao
Journal:  Neurosci Biobehav Rev       Date:  2010-08-18       Impact factor: 8.989

Review 4.  The hormonal signature of energy deficit: Increasing the value of food reward.

Authors:  Sarah H Lockie; Zane B Andrews
Journal:  Mol Metab       Date:  2013-08-19       Impact factor: 7.422

Review 5.  Dopamine and addiction: what have we learned from 40 years of research.

Authors:  Marcello Solinas; Pauline Belujon; Pierre Olivier Fernagut; Mohamed Jaber; Nathalie Thiriet
Journal:  J Neural Transm (Vienna)       Date:  2018-12-19       Impact factor: 3.575

6.  Hypolocomotor effects of acute and daily d-amphetamine in mice lacking the dopamine transporter.

Authors:  C Spielewoy; G Biala; C Roubert; M Hamon; C Betancur; B Giros
Journal:  Psychopharmacology (Berl)       Date:  2001-09-11       Impact factor: 4.530

7.  Essential role for RGS9 in opiate action.

Authors:  Venetia Zachariou; Dan Georgescu; Nick Sanchez; Zia Rahman; Ralph DiLeone; Olivier Berton; Rachael L Neve; Laura J Sim-Selley; Dana E Selley; Stephen J Gold; Eric J Nestler
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-31       Impact factor: 11.205

8.  Long-lasting effects of adolescent oxycodone exposure on reward-related behavior and gene expression in mice.

Authors:  Victoria Sanchez; Marco D Carpenter; Nicole L Yohn; Julie A Blendy
Journal:  Psychopharmacology (Berl)       Date:  2016-09-13       Impact factor: 4.530

9.  Morphine-induced physiological and behavioral responses in mice lacking G protein-coupled receptor kinase 6.

Authors:  Kirsten M Raehal; Cullen L Schmid; Ivan O Medvedev; Raul R Gainetdinov; Richard T Premont; Laura M Bohn
Journal:  Drug Alcohol Depend       Date:  2009-06-03       Impact factor: 4.492

10.  Dopamine promotes striatal neuronal apoptotic death via ERK signaling cascades.

Authors:  Jun Chen; Milan Rusnak; Paul J Lombroso; Anita Sidhu
Journal:  Eur J Neurosci       Date:  2009-01       Impact factor: 3.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.